Over 2023, Ro used out-of-home to establish itself as a leader in the GLP-1 telehealth category. Our goal was to create striking, visceral imagery with copy that boldly declared our support for obesity medical care.

Times Square, New York
Our focus on empowered portraiture and visceral injection shots caused quite a stir in the media. From a copy perspective, we mainly highlighted straightforward product copy, with a smaller role for our brand statement.

Los Angeles
In LA, we doubled down on copy, challenging much of the conversation happening in the media around celebrity GLP-1 usage and the worthiness of those with obesity using the medication during a shortage.

Boston South Station
In Q4 2023, we evolved the messaging to speak to both patient pain points and Ro’s role in the patient journey.